about
Combined effects of oleoyl-estrone and a β3-adrenergic agonist (CL316,243) on lipid stores of diet-induced overweight male Wistar ratsNotch signaling pathway activation in normal and hyperglycemic rats differs in the stem cells of visceral and subcutaneous adipose tissue.Early ERK1/2 activation promotes DRP1-dependent mitochondrial fission necessary for cell reprogramming.Comparative effects of oleoyl-estrone and a specific beta3-adrenergic agonist (CL316, 243) on the expression of genes involved in energy metabolism of rat white adipose tissue.Selective inhibition of sphingosine kinase-1 protects adipose tissue against LPS-induced inflammatory response in Zucker diabetic fatty rats.Site-specific modulation of white adipose tissue lipid metabolism by oleoyl-estrone and/or rosiglitazone in overweight rats.Technical note: Measurement of total estrone content in foods. Application to dairy products.Tamoxifen does not prevent the mobilization of body lipids elicited by oleoyl-estrone.Short-term oral oleoyl-estrone treatment increases plasma cholesterol turnover in the rat.Systems biology approach to identify alterations in the stem cell reservoir of subcutaneous adipose tissue in a rat model of diabetes: effects on differentiation potential and function.Short-term oral oleoyl-estrone decreases the expression of ghrelin in the rat stomach.Effects of oleoyl-estrone with dexfenfluramine, sibutramine or phentermine on overweight rats.Effects of oral estrone on rat energy balance.Platelets derived from the bone marrow of diabetic animals show dysregulated endoplasmic reticulum stress proteins that contribute to increased thrombosis.Estimation of the metabolizable energy equivalence of dietary proteins.Inhibition of Notch rescues the angiogenic potential impaired by cardiovascular risk factors in epicardial adipose stem cells.The subcutaneous adipose tissue reservoir of functionally active stem cells is reduced in obese patientsEffects of Combined Oleoyl-Estrone and Rimonabant on Overweight Rats
P50
Q21710686-D679B537-7AAA-44D8-8386-D400FFE79040Q34712757-76CCF0E3-BAEA-45B3-97D4-946EE75A1452Q38782294-033CD3F8-46B7-41BD-9F52-F9BDD7432911Q39687972-29D1E1E2-BC7E-4B1D-BFC4-6B045DFAE486Q42799060-75CD7162-E730-499F-9E98-4C00495AFE86Q43145420-04DCDB2F-1F8B-476F-B112-C361E4BB0587Q45029667-C391C87A-5B60-4763-9E4F-97FB8FE808C3Q45090433-BA3536E2-1F75-4C31-8FC5-8FE2753637E2Q45239202-FB5D1A17-BEAD-41F0-AD0A-3CAB2815377BQ46003749-B9D9791F-A2BF-4D1E-9623-96676B79448EQ46321050-5B867C9F-5186-4565-A18C-D1F69554373BQ46464862-2C6EB529-E7BF-4DD4-B0B7-2E4AE05E8448Q46483642-C0DB7714-4EF2-4BF6-8CD4-D5E5F1D7E82AQ50492969-EB90EC91-0E44-452F-94CA-77FF91F776BDQ51929038-36885029-0F5A-4618-AC3D-573E4AD643D9Q53106096-E169D872-FE09-4158-9B03-22FC51AA239CQ59255837-A2C72A12-F865-44A2-83DE-27C9CF0DA6A6Q59255850-22EFBFE4-1DD0-470F-9819-1CAE9473FCAF
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Raquel Ferrer-Lorente
@ast
Raquel Ferrer-Lorente
@en
Raquel Ferrer-Lorente
@es
Raquel Ferrer-Lorente
@nl
Raquel Ferrer-Lorente
@sl
type
label
Raquel Ferrer-Lorente
@ast
Raquel Ferrer-Lorente
@en
Raquel Ferrer-Lorente
@es
Raquel Ferrer-Lorente
@nl
Raquel Ferrer-Lorente
@sl
prefLabel
Raquel Ferrer-Lorente
@ast
Raquel Ferrer-Lorente
@en
Raquel Ferrer-Lorente
@es
Raquel Ferrer-Lorente
@nl
Raquel Ferrer-Lorente
@sl
P1053
M-4416-2014
P106
P21
P31
P3829
P496
0000-0002-2052-9011